Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia
- PMID: 18991338
- PMCID: PMC2648510
- DOI: 10.1002/ana.21451
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia
Abstract
Objective: Alzheimer's disease (AD) is found at autopsy in up to one third of patients with primary progressive aphasia (PPA), but clinical features that predict AD pathology in PPA are not well defined. We studied the relationships between language presentation, Abeta amyloidosis, and glucose metabolism in three PPA variants using [11C]-Pittsburgh compound B ([11C]PIB) and [18F]-labeled fluorodeoxyglucose positron emission tomography ([18F]FDG-PET).
Methods: Patients meeting PPA criteria (N = 15) were classified as logopenic aphasia (LPA), progressive nonfluent aphasia (PNFA), or semantic dementia (SD) based on language testing. [11C]PIB distribution volume ratios were calculated using Logan graphical analysis (cerebellar reference). [18F]FDG images were normalized to pons. Partial volume correction was applied.
Results: Elevated cortical PIB (by visual inspection) was more common in LPA (4/4 patients) than in PNFA (1/6) and SD (1/5) (p < 0.02). In PIB-positive PPA, PIB uptake was diffuse and indistinguishable from the pattern in matched AD patients (n = 10). FDG patterns were focal and varied by PPA subtype, with left temporoparietal hypometabolism in LPA, left frontal hypometabolism in PNFA, and left anterior temporal hypometabolism in SD. FDG uptake was significant asymmetric (favoring left hypometabolism) in PPA (p < 0.005) but not in AD.
Interpretation: LPA is associated with Abeta amyloidosis, suggesting that subclassification of PPA based on language features can help predict the likelihood of AD pathology. Language phenotype in PPA is closely related to metabolic changes that are focal and anatomically distinct between subtypes, but not to amyloid deposition patterns that are diffuse and similar to AD.
Figures



Similar articles
-
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014. Neuroimage Clin. 2014. PMID: 24818077 Free PMC article.
-
Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.Arch Neurol. 2007 Aug;64(8):1140-4. doi: 10.1001/archneur.64.8.1140. Arch Neurol. 2007. PMID: 17698704
-
Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.Arch Neurol. 2010 May;67(5):596-605. doi: 10.1001/archneurol.2010.78. Arch Neurol. 2010. PMID: 20457960
-
PET imaging of brain amyloid in dementia: a review.Int J Geriatr Psychiatry. 2011 Oct;26(10):991-9. doi: 10.1002/gps.2640. Epub 2010 Dec 28. Int J Geriatr Psychiatry. 2011. PMID: 21905095 Review.
-
Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.J Neurol. 2017 Jan;264(1):121-130. doi: 10.1007/s00415-016-8324-8. Epub 2016 Nov 4. J Neurol. 2017. PMID: 27815682 Review.
Cited by
-
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):302-9. doi: 10.1097/WAD.0b013e31828cc357. Alzheimer Dis Assoc Disord. 2013. PMID: 23518664 Free PMC article.
-
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.Brain Lang. 2015 Mar;142:45-53. doi: 10.1016/j.bandl.2015.01.009. Epub 2015 Feb 3. Brain Lang. 2015. PMID: 25658633 Free PMC article.
-
Phonological short-term memory in logopenic variant primary progressive aphasia and mild Alzheimer's disease.Cortex. 2015 Oct;71:183-9. doi: 10.1016/j.cortex.2015.07.003. Epub 2015 Jul 16. Cortex. 2015. PMID: 26232551 Free PMC article.
-
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels.Alzheimers Res Ther. 2020 Oct 19;12(1):133. doi: 10.1186/s13195-020-00702-6. Alzheimers Res Ther. 2020. PMID: 33076977 Free PMC article.
-
Clinical phenotypes and genetic biomarkers of FTLD.J Neural Transm (Vienna). 2012 Jul;119(7):851-60. doi: 10.1007/s00702-012-0804-0. Epub 2012 Apr 19. J Neural Transm (Vienna). 2012. PMID: 22527778 Review.
References
-
- Mesulam MM. Slowly progressive aphasia without generalized dementia. Annals of Neurology. 1982;11:592–598. - PubMed
-
- Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49:425–432. - PubMed
-
- Sonty SP, Mesulam MM, Thompson CK, et al. Primary progressive aphasia: PPA and the language network. Ann Neurol. 2003;53:35–49. - PubMed
-
- Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996–2005. - PubMed
-
- Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59:156–165. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous